Pyrethroids Survey in China

Date: May 23, 2013
Pages: 99
Price:
US$ 11,917.24
License [?]:
Publisher: Guangzhou CCM Information Science & Technology Co., Ltd. (CCM)
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: P319112A403EN
Leaflet:

Download PDF Leaflet

Pyrethroids Survey in China
This is CCM's second edition report of China's pyrethroids industry, finished in May 2013. Importance is attached to the following parts:
  • Investigate all the data related to pyrethroids technical in China in the past years, including registration, supply, demand, export, price, etc.
  • Introduce the major pyrethroids from the aspects of capacity, output, consumption and key producers.
  • Identify the leading players of pyrethroids industry in China.
  • Emphasize on consumption volume and marekt value of pyrethroids in 2008-2012, as well as the consumption structure by application areas.
  • Figure out the development status and influencing factors including drivers and barriers.
  • Forecast on pyrethroids from supply to demand in the future five years.
EXECUTIVE SUMMARY

INTRODUCTION & METHODOLOGY


1 OVERVIEW OF PYRETHROIDS INDUSTRY IN CHINA

1.1 Definition and classification of pyrethroids
1.2 Development history of pyrethroids industry in China
1.3 Position of pyrethroids in Chinese insecticide industry

2 SUPPLY AND DEMAND OF PYRETHROIDS IN CHINA

2.1 Summary of supply and demand
  2.1.1 Supply summary (capacity & output, key producers), 2008-2012
  2.1.2 Demand summary (volume & value, application areas), 2008-2012
2.2 Supply and demand of key products
  2.2.1 Lambda-cyhalothrin
    2.2.1.1 Registration
    2.2.1.2 Production situation, 2008-2012
    2.2.1.3 Export situation, 2010-2012
    2.2.1.4 Price, 2008-2013
    2.2.1.5 Consumption situation, 2008-2012
    2.2.1.6 Outlook, 2013-2017
  2.2.2 Bifenthrin
    2.2.2.1 Registration
    2.2.2.2 Production situation, 2008-2012
    2.2.2.3 Export situation, 2010-2012
    2.2.2.4 Price, 2008-2013
    2.2.2.5 Consumption situation, 2008-2012
    2.2.2.6 Outlook, 2013-2017
  2.2.3 Deltamethrin
    2.2.3.1 Registration
    2.2.3.2 Production situation, 2008-2012
    2.2.3.3 Export situation, 2010-2012
    2.2.3.4 Price, 2008-2013
    2.2.3.5 Consumption situation, 2008-2012
    2.2.3.6 Outlook, 2013-2017
  2.2.4 Cypermethrin
    2.2.4.1 Registration
    2.2.4.2 Production situation, 2008-2012
    2.2.4.3 Export situation, 2010-2012
    2.2.4.4 Price, 2008-2013
    2.2.4.5 Consumption situation, 2008-2012
    2.2.4.6 Outlook, 2013-2017
  2.2.5 Fenpropathrin
    2.2.5.1 Registration
    2.2.5.2 Production situation, 2008-2012
    2.2.5.3 Export situation, 2010-2012
    2.2.5.4 Price, 2008-2012
    2.2.5.5 Consumption situation, 2008-2012
    2.2.5.6 Outlook, 2013-2017
  2.2.6 Fenvalerate
    2.2.6.1 Registration
    2.2.6.2 Production situation, 2008-2012
    2.2.6.3 Export situation, 2010-2012
    2.2.6.4 Price, 2008-2013
    2.2.6.5 Consumption situation, 2008-2012
    2.2.6.6 Outlook, 2013-2017
  2.2.7 Esfenvalerate
    2.2.7.1 Registration
    2.2.7.2 Production situation, 2008-2012
    2.2.7.3 Export situation, 2010-2012
    2.2.7.4 Price, 2008-2012
    2.2.7.5 Consumption situation, 2008-2012
    2.2.7.6 Outlook, 2013-2017
  2.2.8 Cyfluthrin
    2.2.8.1 Registration
    2.2.8.2 Production situation, 2008-2012
    2.2.8.3 Export situation, 2010-2012
    2.2.8.4 Price, 2008-2013
    2.2.8.5 Consumption situation, 2008-2012
    2.2.8.6 Outlook, 2013-2017
  2.2.9 Permethrin
    2.2.9.1 Registration
    2.2.9.2 Production situation, 2008-2012
    2.2.9.3 Export situation, 2010-2012
    2.2.9.4 Price, 2008-2012
    2.2.9.5 Consumption situation, 2008-2012
    2.2.9.6 Outlook, 2013-2017
  2.2.10 Beta-cypermethrin
    2.2.10.1 Registration
    2.2.10.2 Production situation, 2008-2012
    2.2.10.3 Export situation, 2010-2012
    2.2.10.4 Price, 2008-2013 80
    2.2.10.5 Consumption situation, 2008-2012
    2.2.10.6 Outlook, 2013-2017

3 KEY FACTORS INFLUENCING DEVELOPMENT OF PYRETHROIDS

3.1 Governmental policies
3.2 Economic factors
3.3 Social environment
3.4 Industry competition
3.5 Production technology

4 SUPPLY & DEMAND FORECAST, 2013-2017

5 RISK ASSESSMENT AND MARKET OPPORTUNITIES

LIST OF TABLES

Table 1.1-1 Classification of pyrethroids by chemical structure
Table 1.1-2 Classification of pyrethroids by photosensitivity
Table 1.3-1 Classification and major products of insecticides in China, 2012
Table 2.1.1-1 Production situation of key pyrethroids technical in China, 2008-2012
Table 2.1.1-2 China's top 9 pyrethroid producers and their main products, 2012
Table 2.1.1-3 Production situation of China's top 9 pyrethroid technical producers, 2008-2012
Table 2.1.2-1 Consumption volume of key pyrethroids in China, 2008-2012, tonne
Table 2.1.2-2 Market value of key pyrethroids in China, 2008-2012, million USD
Table 2.1.2-3 Consumption structure of key pyrethroids by application areas in China, 2008-2012
Table 2.2.1.1-1 Valid registrations of lambda-cyhalothrin in China, as of April 2013
Table 2.2.1.1-2 Valid registrations of lambda-cyhalothrin technical in China, as of April 2013
Table 2.2.1.1-3 Valid registrations of lambda-cyhalothrin formulations in China, as of April 2013
Table 2.2.1.2-1 Production status and information of lambda-cyhalothrin technical producers in China, as of April 2013
Table 2.2.1.2-2 Capacity and output of main lambda-cyhalothrin technical producers in China, 2008-2012, capacity: t/a, output: tonne
Table 2.2.1.3-1 Export of lambda-cyhalothrin by month, 2012
Table 2.2.1.3-2 Export of lambda-cyhalothrin by month, 2011
Table 2.2.1.3-3 Export of lambda-cyhalothrin by month, 2010
Table 2.2.1.3-4 Export of lambda-cyhalothrin by destination, 2012
Table 2.2.1.3-5 Export of lambda-cyhalothrin by destination, 2011
Table 2.2.1.3-6 Export of lambda-cyhalothrin by destination, 2010
Table 2.2.1.3-7 Export of lambda-cyhalothrin by exporter, 2012
Table 2.2.1.3-8 Export of lambda-cyhalothrin by exporter, 2011
Table 2.2.1.3-9 Export of lambda-cyhalothrin by exporter, 2010
Table 2.2.2.1-1 Valid registrations of bifenthrin in China, as of April 2013
Table 2.2.2.1-2 Valid registrations of bifenthrin technical in China, as of April 2013
Table 2.2.2.1-3 Valid registrations of bifenthrin formulations in China, as of April 2013
Table 2.2.2.2-1 Production status and information of bifenthrin technical producers in China, as of April 2013
Table 2.2.2.2-2 Capacity and output of main bifenthrin technical producers in China, 2008-2012, capacity: t/a, output: tonne
Table 2.2.2.3-1 Export volume of bifenthrin by month, 2012
Table 2.2.2.3-2 Export volume of bifenthrin by month, 2011
Table 2.2.2.3-3 Export volume of bifenthrin by month, 2010
Table 2.2.2.3-4 Export of bifenthrin by destination, 2012
Table 2.2.2.3-5 Export of bifenthrin by destination, 2011
Table 2.2.2.3-6 Export of bifenthrin by destination, 2010
Table 2.2.2.3-7 Export of bifenthrin by exporter, 2012
Table 2.2.2.3-8 Export of bifenthrin by exporter, 2011
Table 2.2.2.3-9 Export of bifenthrin by exporter, 2010
Table 2.2.3.1-1 Valid registrations of deltamethrin in China, as of April 2013
Table 2.2.3.1-2 Valid registrations of deltamethrin technical in China, as of April 2013
Table 2.2.3.1-3 Valid registrations of deltamethrin formulations in China, as of April 2013
Table 2.2.3.2-1 Basic information on the main deltamethrin technical manufacturers in China
Table 2.2.3.2-2 Capacity and output of the main deltamethrin technical manufacturers in China, 2008-2012
Table 2.2.4.1-1 Valid registrations of cypermethrin in China, as of April 2013
Table 2.2.4.1-2 Valid registrations of cypermethrin technical in China, as of April 2013
Table 2.2.4.1-3 Valid registrations of cypermethrin formulations in China, as of April 2013
Table 2.2.4.2-1 Basic information on the main cypermethrin technical manufacturers in China, 2012
Table 2.2.4.2-2 Capacity and output of the main cypermethrin technical manufacturers in China, 2008-2012
Table 2.2.5.1-1 Valid registrations of fenpropathrin in China, as of April 2013
Table 2.2.5.1-2 Valid registrations of fenpropathrin technical in China, as of April 2013
Table 2.2.5.1-3 Valid registrations of fenpropathrin formulations in China, as of April 2013
Table 2.2.5.2-1 Basic information on the main fenpropathrin technical manufacturers in China, 2012
Table 2.2.5.2-2 Capacity and output of the main fenpropathrin technical manufacturers in China, 2008-2012
Table 2.2.6.1-1 Valid registrations of fenvalerate in China, as of April 2013
Table 2.2.6.1-2 Valid registrations of fenvalerate technical in China, as of April 2013
Table 2.2.6.1-3 Valid registrations of fenvalerate formulations in China, as of April 2013
Table 2.2.6.2-1 Basic information on the main fenvalerate technical manufacturers in China, 2012
Table 2.2.6.2-2 Capacity and output of the main fenvalerate technical manufacturers in China, 2008-2012
Table 2.2.7.1-1 Valid registrations of esfenvalerate in China, as of April 2013
Table 2.2.7.1-2 Valid registrations of esfenvalerate technical in China, as of April 2013
Table 2.2.7.1-3 Valid registrations of esfenvalerate formulations in China, as of April 2013
Table 2.2.7.2-1 Basic information on the main esfenvalerate technical manufacturers in China, 2012
Table 2.2.7.2-2 Capacity and output of the main esfenvalerate technical manufacturers in China, 2008-2012
Table 2.2.8.1-1 Valid registrations of cyfluthrin in China, as of April 2013
Table 2.2.8.1-2 Valid registrations of cyfluthrin technical in China, as of April 2013
Table 2.2.8.1-3 Valid registrations of cyfluthrin formulations in China, as of April 2013
Table 2.2.8.2-1 Basic information on the main cyfluthrin technical manufacturers in China, 2012
Table 2.2.8.2-2 Capacity and output of the main cyfluthrin technical manufacturers in China, 2008-2012
Table 2.2.9.1-1 Valid registrations of permethrin in China, as of April 2013
Table 2.2.9.1-2 Valid registrations of permethrin technical in China, as of April 2013
Table 2.2.9.1-3 Valid registrations of permethrin formulations in China, as of April 2013
Table 2.2.9.2-1 Basic information on the main permethrin technical manufacturers in China
Table 2.2.9.2-2 Capacity and output of the main permethrin technical manufacturers in China, 2008-2012
Table 2.2.10.1-1 Valid registrations of beta-cypermethrin in China, as of April 2013
Table 2.2.10.1-2 Valid registrations of beta-cypermethrin technical in China, as of April 2013
Table 2.2.10.1-3 Valid registrations of beta-cypermethrin formulations in China, as of April 2013
Table 2.2.10.2-1 Basic information on the main beta-cypermethrin technical manufacturers in China, 2012
Table 2.2.10.2-2 Capacity and output of the main beta-cypermethrin technical manufacturers in China, 2008-2012
Table 3.5-1 Technologies to be greatly promoted in China, 2011-2015

LIST OF FIGURES

Figure 2.1.1-1 Production situation of pyrethroids technical in China, 2008-2012
Figure 2.1.2-1 Consumption volume and market value of pyrethoids in China, 2008-2012
Figure 2.2.1.2-1 Capacity and output of lambda-cyhalothrin technical in China, 2008-2012
Figure 2.2.1.2-2 Geographic distribution of capacity of lambda-cyhalothrin technical in China, 2012
Figure 2.2.1.4-1 Ex-works price of lambda-cyhalothrin technical in China, 2008-April 2013
Figure 2.2.1.4-2 Ex-works price of lambda-cyhalothrin formulations in China, 2008-2012
Figure 2.2.1.5-1 Consumption volume and market value of lambda-cyhalothrin formulations in China, 2008-2012
Figure 2.2.1.5-2 Consumption volume of lambda-cyhalothrin by application areas in China, 2008-2012
Figure 2.2.1.6-1 Output forecast of lambda-cyhalothrin technical in China, 2013-2017
Figure 2.2.1.6-2 Forecast on consumption volume and market value of lambda-cyhalothrin formulations in China, 2013-2017
Figure 2.2.2.2-1 Capacity and outupt of bifenthrin technical in China, 2008-2012
Figure 2.2.2.2-2 Geographic distribution of capacity of bifenthrin technical in China, 2012
Figure 2.2.2.4-1 Ex-works price of bifenthrin technical in China, 2008-April 2013
Figure 2.2.2.4-2 Ex-works price of bifenthrin formulations in China, 2008-2012
Figure 2.2.2.5-1 Consumption volume and market value of bifenthrin formulations in China, 2008-2012
Figure 2.2.2.5-2 Consumption volume of bifenthrin by application areas in China, 2008-2012
Figure 2.2.2.6-1 Output forecast of bifenthrin technical in China, 2013-2017
Figure 2.2.2.6-2 Forecast on consumption volume and market value of bifenthrin formulations in China, 2013-2017
Figure 2.2.3.2-1 Capacity and output of deltamethrin technical in China, 2008-2012
Figure 2.2.3.4-1 Ex-works price of deltamethrin technical in China, 2008-April 2013
Figure 2.2.3.5-1 Consumption volume and market value of deltamethrin formulations in China, 2008-2012
Figure 2.2.3.5-2 Consumption volume of deltamethrin by application areas in China, 2008-2012
Figure 2.2.3.6-1 Output forecast of deltamethrin technical in China, 2013-2017
Figure 2.2.3.6-2 Forecast on consumption volume and market value of deltamethrin formulations in China, 2013-2017
Figure 2.2.4.2-1 Capacity and output of cypermethrin technical in China, 2008-2012
Figure 2.2.4.4-1 Ex-works price of cypermethrin technical in China, 2008-April 2013
Figure 2.2.4.5-1 Consumption volume and market value of cypermethrin formulations in China, 2008-2012
Figure 2.2.4.5-2 Consumption volume of cypermethrin by application areas in China, 2008-2012
Figure 2.2.4.6-1 Output forecast of cypermethrin technical in China, 2013-2017
Figure 2.2.4.6-2 Forecast on consumption volume and market value of cypermethrin formulations in China, 2013-2017
Figure 2.2.5.2-1 Capacity and output of fenpropathrin technical in China, 2008-2012
Figure 2.2.5.4-1 Ex-works price of fenpropathrin technical (92%) in China, 2008-2012
Figure 2.2.5.5-1 Consumption volume and market value of fenpropathrin formulations in China, 2008-2012
Figure 2.2.5.5-2 Consumption volume of fenpropathrin by application areas in China, 2008-2012
Figure 2.2.5.6-1 Output forecast of fenpropathrin technical in China, 2013-2017
Figure 2.2.5.6-2 Forecast on consumption volume and market value of fenpropathrin formulations in China, 2013-2017
Figure 2.2.6.2-1 Capacity and output of fenvalerate technical in China, 2008-2012
Figure 2.2.6.4-1 Ex-works price of fenvalerate technical in China, 2008-April 2013
Figure 2.2.6.5-1 Consumption volume and market value of fenvalerate formulations in China, 2008-2012
Figure 2.2.6.5-2 Consumption volume of fenvalerate by application areas in China, 2008-2012
Figure 2.2.6.6-1 Output forecast of fenvalerate technical in China, 2013-2017
Figure 2.2.6.6-2 Forecast on consumption volume and market value of fenvalerate formulations in China, 2013-2017
Figure 2.2.7.2-1 Capacity and output of esfenvalerate technical in China, 2008-2012
Figure 2.2.7.4-1 Ex-works price of esfenvalerate technical (95%) in China, 2008-2012
Figure 2.2.7.5-1 Consumption volume and market value of esfenvalerate formulations in China, 2008-2012
Figure 2.2.7.5-2 Consumption volume of esfenvalerate by application areas in China, 2008-2012
Figure 2.2.7.6-1 Output forecast of esfenvalerate technical in China, 2013-2017
Figure 2.2.7.6-2 Forecast on consumption volume and market value of esfenvalerate formulations in China, 2013-2017
Figure 2.2.8.2-1 Capacity and output of cyfluthrin technical in China, 2008-2012
Figure 2.2.8.4-1 Ex-works price of cyfluthrin technical in China, 2008-April 2013
Figure 2.2.8.5-1 Consumption volume and market value of cyfluthrin formulations in China, 2008-2012
Figure 2.2.8.5-2 Consumption volume of cyfluthrin by application areas in China, 2008-2012
Figure 2.2.8.6-1 Output forecast of cyfluthrin technical in China, 2013-2017
Figure 2.2.8.6-2 Forecast on consumption volume and market value of cyfluthrin formulations in China, 2013-2017
Figure 2.2.9.2-1 Capacity and output of permethrin technical in China, 2008-2012
Figure 2.2.9.4-1 Ex-works price of permethrin technical in China, 2008-2012
Figure 2.2.9.5-1 Consumption volume and market value of permethrin formulations in China, 2008-2012
Figure 2.2.9.5-2 Consumption volume of permethrin by application areas in China, 2008-2012
Figure 2.2.9.6-1 Output forecast of permethrin technical in China, 2013-2017
Figure 2.2.9.6-2 Forecast on consumption volume and market value of permethrin formulations in China, 2013-2017
Figure 2.2.10.2-1 Capacity and output of beta-cypermethrin technical in China, 2008-2012
Figure 2.2.10.4-1 Ex-works price of beta-cypermethrintechnical in China, 2008-April 2013
Figure 2.2.10.5-1 Consumption volume and market value of beta-cypermethrin formulations in China, 2008-2012
Figure 2.2.10.5-2 Consumption volume of beta-cypermethrin by application areas in China, 2008-2012
Figure 2.2.10.6-1 Output forecast of beta-cypermethrin technical in China, 2013-2017
Figure 2.2.10.6-2 Forecast on consumption volume and market value of beta-cypermethrin formulations in China, 2013-2017
Figure 3.2-1 Per capita disposable income of urban residents in China, 2000-2012
Figure 3.2-2 Per capita net income of rural residents in China, 2000-2012
Figure 4-1 Forecast on output of pyrethroids technical in China, 2013-2017
Figure 4-2 Forecast on consumption volume and market value of pyrethroids in China, 2013-2017
Skip to top


Fipronil Survey in China US$ 8,640.00 Jun, 2010 · 56 pages
Survey of Glycine in China US$ 9,682.76 Jan, 2013 · 51 pages
Seed Treatment Survey in China US$ 9,682.76 Jan, 2010 · 94 pages
Seed Survey in China US$ 11,917.24 Apr, 2010 · 119 pages
Monoisopropylamine (MIPA) survey in China US$ 7,448.28 May, 2010 · 40 pages

Ask Your Question

Pyrethroids Survey in China
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: